what is the maintenance dose of tirzepatide therapy on semaglutide or If you’re on a maintenance
Description
Based on these results, in January 2025 the FDA approved Ozempic for a new indication : reducing the risk of kidney disease worsening, kidney failure, and cardiovascular death in adults with type 2 diabetes and CKD
This result is almost as strong as those seen with the once-weekly 2.4 mg injection in clinical trials
Before starting a GLP-1 regimen, we encourage individuals to take our free assessment quiz
Effective for Some Ozempic may be an effective option for weight loss for some people
&srotate=0)
